Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT00803374
What this trial is testing

Combination of Anti-CD137 & Ipilimumab in Patients With Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb
Early research (Phase 1)Ended earlyNCT02714374
What this trial is testing

GL-ONC1 Administered Intravenously Prior to Surgery to Patients With Solid Organ Cancers

Who this might be right for
Solid Organ Cancers
Andrew Lowy 5
Testing effectiveness (Phase 2)WithdrawnNCT01851408
What this trial is testing

Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable Melanoma

Who this might be right for
MelanomaRecurrent MelanomaStage III Melanoma+1 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT06319196
What this trial is testing

Clear Me: Interception Trial to Detect and Clear Molecular Residual Disease in Patients With High-risk Melanoma

Who this might be right for
Cutaneous MelanomaMelanoma Stage IVMucosal Melanoma
University Health Network, Toronto 54
Testing effectiveness (Phase 2)Study completedNCT00289640
What this trial is testing

Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 210
Testing effectiveness (Phase 2)Ended earlyNCT02062359
What this trial is testing

T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Melanoma

Who this might be right for
Metastatic CancerMetastatic Melanoma
National Cancer Institute (NCI) 2
Early research (Phase 1)Active Not RecruitingNCT03311308
What this trial is testing

A Trial of Pembrolizumab and Metformin Versus Pembrolizumab Alone in Advanced Melanoma

Who this might be right for
Advanced Melanoma
Yana Najjar 23
Testing effectiveness (Phase 2)Ended earlyNCT00085059
What this trial is testing

Boron Neutron Capture Therapy Using Boronophenylalanine-Fructose Complex in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
European Organisation for Research and Treatment of Cancer - EORTC 4
Testing effectiveness (Phase 2)Study completedNCT00085306
What this trial is testing

Interferon Beta in Treating Patients With Metastatic Cutaneous Melanoma or Ocular Melanoma

Who this might be right for
Stage IV MelanomaRecurrent Melanoma
Case Comprehensive Cancer Center 21
Testing effectiveness (Phase 2)UnknownNCT05097378
What this trial is testing

Perioperative Encobini in BRAFV600 Mutant Stage III (B/C/D) or Oligometastatic Stage IV Melanoma

Who this might be right for
MelanomaCancer
CCTU- Cancer Theme 45
Not applicableStudy completedNCT00006243
What this trial is testing

Vaccine Therapy and Sargramostim in Treating Patients With Stage IV Malignant Melanoma

Who this might be right for
Recurrent MelanomaStage IV Melanoma
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT02009397
What this trial is testing

A Phase I/II Open-Label Study of Ipilimumab and GM-CSF Administered to Unresectable Stage IIIC and Stage IV Melanoma Patients

Who this might be right for
Metastatic Melanoma
University of Louisville 27
Testing effectiveness (Phase 2)Looking for participantsNCT07155317
What this trial is testing

Time-of-Day Specified Immunotherapy for Advanced Melanoma, The TIME Trial

Who this might be right for
Advanced Acral MelanomaAdvanced Cutaneous MelanomaAdvanced Mucosal Melanoma+7 more
Emory University 99
Not applicableLooking for participantsNCT06199713
What this trial is testing

Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients

Who this might be right for
MelanomaMelanoma Stage IIIMelanoma Stage IV+1 more
University of Wisconsin, Madison 24
Early research (Phase 1)Study completedNCT01489059
What this trial is testing

Safety Study of IL-21/Ipilimumab Combination in the Treatment of Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 42
Early research (Phase 1)Active Not RecruitingNCT02721459
What this trial is testing

XL888 + Vemurafenib + Cobimetinib for Unresectable BRAF Mutated Stage III/IV Melanoma

Who this might be right for
MelanomaSkin Cancer
H. Lee Moffitt Cancer Center and Research Institute 26
Testing effectiveness (Phase 2)Ended earlyNCT00505635
What this trial is testing

Biochemotherapy With Temozolomide for Metastatic Melanoma

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT03767348
What this trial is testing

Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE)

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)Microsatellite Instability-High (MSI-H)Non-melanoma Skin Cancer (NMSC)+1 more
Replimune, Inc. 340
Testing effectiveness (Phase 2)Study completedNCT00514085
What this trial is testing

Interleukin-21 in Treating Patients With Metastatic or Recurrent Malignant Melanoma

Who this might be right for
Melanoma (Skin)
NCIC Clinical Trials Group 40
Early research (Phase 1)Study completedNCT02434354
What this trial is testing

A Tissue Collection Study of Pembrolizumab (MK-3475) in Subjects With Resectable Advanced Melanoma

Who this might be right for
Malignant Melanoma
Abramson Cancer Center at Penn Medicine 33
Next Page